Ines Semendric
University of Adelaide
PsychologyCognitionSurvivorship curveIntensive care medicineQualitative researchSide effectReactivity (psychology)RodentMEDLINEQuality (business)PsycINFOMicrogliaGuidelineCINAHLCompliance (psychology)Cognitive ChangesPopulationAnimal Ethics CommitteesCognitive impairmentChemotherapy inducedNursing researchFocus groupBioinformaticsMedicineGerontologyActivities of daily livingNeuroinflammation
2Publications
1H-index
1Citations
Publications 2
Newest
#1Rebecca P. George (University of Adelaide)H-Index: 2
#2Ines Semendric (University of Adelaide)H-Index: 1
Last. Alexandra L. Whittaker (University of Adelaide)H-Index: 11
view all 6 authors...
Patients diagnosed with cancer are often plagued with debilitating side effects post-chemotherapy treatment. One such side effect is chemotherapy-induced cognitive impairment or 'chemobrain'. Rodent models are commonly used to investigate pathogenesis and potential therapeutic strategies. However, concerns have been raised regarding inadequacies in reporting of animal studies rendering them unreliable and irreproducible. The aim of this systematic review was to assess compliance with the ARRIVE ...
Source
#1Rebecca P. George (University of Adelaide)H-Index: 2
#2Ines Semendric (University of Adelaide)H-Index: 1
Last. Alexandra L. Whittaker (University of Adelaide)H-Index: 11
view all 4 authors...
Abstract Background Chemotherapy-induced cognitive impairment (CICI) is a debilitating side effect arising from chemotherapy treatments. The condition is characterised by a range of cognitive deficits including impairment to memory, attention, and concentration. Whilst the underlying mechanisms that contribute to CICI remain unclear, neuroinflammation has been suggested as one key contributor. Method A comprehensive systematic search of EMBASE and Medline via PubMed was conducted to identify stu...
Source